Results 51 to 60 of about 2,953,647 (260)
Pediatric Blood &Cancer, EarlyView.ABSTRACT Purpose Chemoimmunotherapy with irinotecan, temozolomide, and dinutuximab (I/T/DIN) has emerged as first‐line therapy for relapsed/refractory (r/r) high‐risk neuroblastoma (HRNB) in North America. Topotecan and cyclophosphamide (T/C) are often used in combination with dinutuximab in the setting of lack of response, progression, or incomplete ...
Benjamin J. Lerman +17 more
wiley +1 more source
Clinical Course and Impact of Breaks in Therapy for Children With Relapsed/Refractory Solid Tumors
Pediatric Blood &Cancer, EarlyView.ABSTRACT Introduction Pediatric relapsed or refractory (R/R) solid tumors carry a dismal prognosis, and postrelapse patient experiences are not well described. We present postrelapse outcomes, including number of R/R events and subsequent therapy regimens.
Matthew T. McEvoy +5 more
wiley +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Neuropsychological complications may impair the qualitative prognosis of patients with pediatric brain tumors. However, multifaceted evaluations cannot be conducted in all patients because they are time consuming and burdensome for patients.
Ami Tabata +9 more
wiley +1 more source
Экспериментальная психология, 2018 The topic of the relative impact of motivation and intelligence was investigated on the sample of students of Humanities at one of the ordinary universities of Moscow.
N.A. Almayev +3 more
doaj +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Patients with high‐risk neuroblastoma who either are refractory to induction chemotherapy or relapse following multi‐modal treatment have a dismal prognosis. Based on data from the BEACON trial, since 2021 the UK national guidelines recommend bevacizumab, irinotecan, and temozolomide (BIT) for patients with relapsed/refractory ...
Thomas J. Jackson +20 more
wiley +1 more source
Frontiers in NeurologyPatients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Post-Acute Sequelae of COVID-19 (PASC) often have neurocognitive complaints that involve memory and concentration problems and difficulties paying attention.
Ariadna Sandoval +2 more
doaj +1 more source
Patient Related Outcome Measures, 2021 Minji K Lee,1 Jennifer L St Sauver,1,2 Roger T Anderson,3 Mark Linzer,4 David T Eton1,2 1Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN, USA; 2Department of Health Sciences Research, Mayo Clinic,
Lee MK +4 more
doaj
Implementing Health‐Related Quality of Life Assessment in Pediatric Oncology: A Feasibility Study
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background There is growing interest in embedding health‐related quality of life (HRQoL) assessment and patient‐reported outcome measures (PROMs) within clinical cancer care. This study evaluated the feasibility, acceptability, and usability of implementing an electronic PROM (ePROM) platform to measure HRQoL in children with cancer ...
Mikaela Doig +13 more
wiley +1 more source
Patient Related Outcome Measures, 2018 Ida Babakhanyan,1,2 Benjamin S McKenna,2 Kaitlin B Casaletto,3 Cindy J Nowinski,4 Robert K Heaton2 1Defense and Veteran’s Brain Injury Center, Camp Pendleton, 2Department of Psychiatry, University of California, San Diego, La Jolla, 3Department of ...
Babakhanyan I +4 more
doaj
Analysis of the psychometric properties of the BRIEF-A in a sample of Mexican college students
Revista de Psicología y Ciencias del Comportamiento de la Unidad Académica de Ciencias Jurídicas y SocialesThe Behavior Rating Inventory of Executive Fun-ction-Adult (BRIEF-A) is one of the most interna-tionally used self-report inventories that assesses the perception of executive functions in adults, in healthy and clinical samples.
Iliana Murguía Álvarez Rubio +4 more
doaj +1 more source